Genfit: H1 2019 Results and R&D Pipeline Progression
GENFIT S.A. - American Depositary Shares (GNFT)
Company Research
Source: GlobeNewswire
GENFIT: H1 2019 RESULTS AND R&D PIPELINE PROGRESSION Cash position of €282 million (€207 million at December 31, 2018)USD $155 million gross proceeds from the IPO on the Nasdaq Global Select marketSignature of a license agreement with Labcorp to expand access to NIS4, a non-invasive diagnostic test to identify and monitor NASH patients, in the clinical research fieldSignature of a license and collaboration agreement with Terns Pharmaceuticals, granting a license to develop and market elafibranor in NASH and PBC in Greater China Launch of a pediatric phase 2 clinical trial evaluating elafibranor in children and adolescents with NASHLaunch of a phase 2 clinical trial evaluating elafibranor’s activity on liver fat composition in NAFLD patientsFDA grants elafibranor Breakthrough Therapy designation for treatment of adults with PBC Lille (France), Cambridge (Massachusetts, United States), September 30, 2019 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company ded
Show less
Read more
Impact Snapshot
Event Time:
GNFT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GNFT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GNFT alerts
High impacting GENFIT S.A. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GNFT
News
- Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus [Yahoo! Finance]Yahoo! Finance
- GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024 [Yahoo! Finance]Yahoo! Finance
- GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024GlobeNewswire
- GENFIT Reports Third Quarter 2024 Financial Information [Yahoo! Finance]Yahoo! Finance
- GENFIT Reports Third Quarter 2024 Financial InformationGlobeNewswire